|
|
National Jewish Medical and Research Center
Research
The programs in clinical and basic research continue to grow with funding from the National Institutes of Health, the Environmental Protection Agency, other federal agencies and the pharmaceutical industry. Faculty members have played major roles in NIH-funded multicenter studies evaluating asthma therapy. The major programs in asthma, inflammation, signal transduction and psychosocial problems in chronic illness have been extremely successful. For seven consecutive years, National Jewish has been ranked the best respiratory hospital in America by U.S. News & World Report.
Faculty are active in a wide range of research areas. Dr. F. Dan Atkins' primary interest is in food allergies. Dr. Mark Boguniewicz researches atopic dermatitis and immunomodulatory therapy and early intervention in the atopic march. Dr. Azzeddine Dakhama's research explores the role of respiratory syncytial virus in post-bronchiolitis wheezing and asthma and the role of neuropeptides in airway inflammation and hyperresponsiveness. Dr. Erwin Gelfand's primary research interests center on allergic airway inflammation and immunodeficiency. Dr. Richard Johnston researches the cell biology of phagocytic cells and immunodeficiency disease. Dr. Henry Milgrom's research interests involve the therapy of asthma and patient adherence to therapy. Dr. Donald Leung investigates the immune mechanisms of allergic diseases, particularly atopic dermatitis and severe asthma. Dr. Andrew Liu is studying allergy and asthma development and prevention, hygiene theory and gene-environment interactions. Dr. Harold Nelson's research involves the pharmacologic treatment of asthma. Dr. Nathan Rabinovitch's research is in environmental triggers of asthma. Dr. Stanley Szefler is interested in the pharmacotherapy of childhood asthma, especially understanding variability in response to treatment. Dr. Carl White is researching lung development and the effects of extremes of oxygen, oxidants and antioxidants in acute and chronic lung injury.
|
|
